$RVVTF PAY ATTENTION TO CATALYSTS I POST BELOW: by

$RVVTF PAY ATTENTION TO CATALYSTS I POST BELOW: by powerbattles

Hospital selection USA trials.

IND FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19

FDA Authorized emergency IND (eIND

UPGRADE OCQB

Grant/Funding opportunities

Sponsor for Trials

Initiate Phase 3 clinical trials of Bucillamine in the treatment of COVID-19 in the U.S

Expand Phase 3 Clinical Trials COVID-19 in Asia-Pacific and Canada

Q2 Submit IND for Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Q2/3 Pre-IND meeting with FDA for Bucillamine in various infectious diseases (undisclosed)

Update the final Prototype orally dissolvable thin film strip for psilocybin

Patents-pending psilocybin formulations

Finalize vendor agreements in project management, medical monitoring, and data management.

Patent News Updates:

[Suppressed Image]

Q3 Initiate Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Q3 Pre-IND meeting with FDA for Psilocybin (undisclosed indications)

Q3/4 Results from Phase 2 clinical study of Bucillamine in the treatment of COVID-19

Q4 Results from Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Q4 Submit FDA IND for Phase 2 clinical study of Bucillamine (undisclosed indication)

Potential buyout could be Billions for a biotech company

Manufacturing deal Atwill Medical Solutions CEO is on the Revive board just signed a deal with VXRT This could lead to potential partnership/deals in the future. IMHO )

Update on its Psilocybin-Based Pharmaceutical Program

Partners to Advance Research for Psilocybin-Based Pharmaceutical Products

Update drugs research partnership agreement (“SRPA”) with the University of Wisconsin-Madison

Link to Revive's subsidiary company

https://www.psilocinpharma.com/


Revive Therapeutics, MindMed, Compass Pathways & Delic Corp Embark on Psychedelics MDMA, Ayahuasca, Psiloc https://financial-news-now.com/revive-therape...-ketamine/


Revive Therapeutics First to Bring Oral Psilocybin Strips to the Market

https://www.greenmarketreport.com/revive-ther...he-market/


Market Size Potential for Psychedelic Medicine
over $200 billion was spent directly on mental health issues in the United States last year. worldwide market equates to $607 billion in direct costs outside of the US, with indirect costs still being multiples of that.

https://mushroomstockindex.com/article/market...-medicine/

$MJ